Lithium intoxication after administration of AT1 blockers.
Zwanzger
P
P
Marcuse
A
A
Boerner
R J
RJ
Walther
A
A
Rupprecht
R
R
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001713:Biphenyl Compounds; D001714:Bipolar Disorder / Q000188:drug therapy / Q000453:epidemiology; D015897:Comorbidity; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D008094:Lithium / Q000097:blood / Q000493:pharmacokinetics* / Q000506:poisoning*; D008875:Middle Aged; D011041:Poisoning / Q000209:etiology / Q000378:metabolism; D013777:Tetrazoles / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D008094:Lithium; C081643:candesartan